AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06490016 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Face to face
Description: In face-to-face training, female internal reproductive organ models, female external reproductive organ models, training content prepared with Braille alphabet, menstrual hygiene management kit (underwear, pads, napkins, calendar) materials will be used. Pictures and audio descriptions will be used in web-based training.~1. st interview: Informed Consent . After the meeting, the Personal Information Form, Menstrual Attitude Scale, Menstrual Symptom Scale, State and Trait Anxiety Scale will be filled out.~2. nd meeting: Module 1-2~3. rd meeting: Module 3- 4~4. th meeting: Module 5.~5. th interview: Menstrual Attitude Scale, Menstrual Symptom Scale, State Anxiety Scale will be completed.~6. th interview: Menstrual Attitude Scale, Menstrual Symptom Scale, State Anxiety Scale will be completed.
Study NCT04914689 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Internal focus of attention feedback
Description: Participants will complete 12 sessions over a 3-week period of functional movement retraining while receiving mirror feedback. Participants will be instructed to perform each functional task in a manner that keeps their knee in line with their toes.
Study NCT04914689 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual internal focus of attention feedback
Description: Participants will complete 12 sessions over a 3-week period of functional movement retraining while receiving visual feedback via laser. Participants will be instructed to perform each functional task in a manner that does causes the laser to move up and down but not side-to-side.
Study NCT04914689 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Auditory external focus of attention feedback
Description: Participants will complete 12 sessions over a 3-week period of functional movement retraining while receiving auditory feedback. Participants will be instructed to perform each functional task in a manner that does not cause the auditory tool to elicit a noise.
Study NCT05115838 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Islatravir
Description: ISL 47, 52, or 57 mg implantable rod placed subdermally on the upper arm.
Study NCT05115838 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo implantable rod placed subdermally on the upper arm.
Study NCT03458221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole Oral Product
Description: Letrozole 2.5mg tablet - 2.5mg once dailty until progression of disease.
Study NCT03458221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bicalutamide Oral Product
Description: Bicalutatmide 150mg tablet - 150mg once daily until progression of disease.
Study NCT03458221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Everolimus Oral Product
Description: Everolimus 10mg tablet - 10mg once daily until progression of disease.
Study NCT03458221 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole Oral Product
Description: Itraconazole 100mg capsule - 300mg twice daily until progression of disease.
Study NCT06261398 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BETTER: motivational interviewing and text messaging
Description: Motivational interviewing to encourage individuals to address their social needs and engage with text messages that allow individuals to connect to their care team, a local organization that can help them address their social needs, and/or a resource that enables them to find help to address their needs based on their zip code.
Study NCT06261398 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: No motivational interviewing or text messages will be provided.
Study NCT05020873 — intervention group
Intervention type: OTHER
Intervention: Crizanlizumab
Description: Prospective observational study. There is no treatment allocation. Patients administered crizanlizumab, that have started before inclusion of the patient into the study will be enrolled.
Study NCT06466226 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Multiple central venous lines in two sites separately
Description: Patients with two central venous lines in two sites separately (two central venous sites).
Study NCT06466226 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Multiple central venous lines in one site (internal jugular vein)
Description: Patients with two concomitant central venous lines in a single internal jugular vein (one central venous site).
Study NCT06005870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib plus RCHOP
Description: Rituximab 375mg/m2 D1; cyclophosphamide 750mg/m2 D2; adriamycin 50 mg/m2 D2 vincristine 1.4mg/m(Max 2mg) D2; prednisone 100mg/d D2-6; Zanubrutinib 160 mg, the bid D1-21
Study NCT06290375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK21542 tablet
Description: once-daily
Study NCT06290375 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: once-daily
Study NCT06171321 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: S-1(Intravenous combined with oral)
Description: Oral combined with intravenous S-1 for ctDNA-positive patients (escalating treatment strategy)
Study NCT06306521 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: BeginNGS Test
Description: Genomic sequencing that screens for over 400 genetic diseases.
Study NCT05932940 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Gonioscopy-Assisted Transluminal Trabeculotomy
Description: Ab interno angle surgery one of MIGS to lower IOP
Study NCT06337071 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
Description: ACYW135 Meningococcal Polysaccharide Conjugate Vaccine was produced by meningococcal polysaccharide from group A, C, Y, W135 and conjugated protein CRM197.
Study NCT06337071 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ACYW135 Meningococcal Polysaccharide Conjugate Vaccine
Description: ACYW135 Meningococcal Polysaccharide Conjugate Vaccine was produced by meningococcal polysaccharide from group A, C, Y, W135 and conjugated protein CRM197.
Study NCT06337071 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ACYW135 Meningococcal Polysaccharide Vaccine
Description: ACYW135 Meningococcal Polysaccharide Vaccine was produced by meningococcal polysaccharide from group A, C, Y, W135.
Study NCT05521230 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Mouthwash
Description: Application of mouthwashes
Study NCT05521230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cymenol mouthwash
Description: Application of mouthwashes
Study NCT05234606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SBT6290
Description: Escalating doses by subcutaneous (SC) injection in 21-day cycles
Study NCT05234606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SBT6290
Description: Dose expansion with the recommended Phase 2 dose (RP2D) by SC injection in 21-day cycles
Study NCT05234606 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pembrolizumab
Description: 200 mg via intravenous (IV) injection in 21-day cycles
Study NCT06365203 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Through knee amputation
Description: Amputation Technique
Study NCT06365203 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Above knee Amputation
Description: Amputation Technique
Study NCT04906980 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JNJ-64281802
Description: JNJ-64281802 will be administered orally.
Study NCT04906980 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo (PEG400) will be administered orally.
Study NCT05270590 — intervention group
Intervention type: PROCEDURE
Intervention: minimally invasive rheumatic mitral valve surgery
Description: First, venous and arterial access was established. Incision establishment: A 4 to 6 cm incision was opened in the chest anterolaterally to the right of the fourth intercostal space (in submamarry vs. peri areolar approach ). The thoracoscope was inserted. Bypass started, and Chitwood occlusion forceps were inserted to block the ascending aorta, purse-string suturing of the cardioplegia cannula and antegradecardioplegia fluid was performed, the interatrial groove was freed, the left atrial incision was made. Removal of the damaged mitral valve mostly by endoscopic surgical instruments (not usually there is a chance for repair), and the mitral valve was sutured intermittently. After examination of the valve location and the opening and closing performance of the valve leaf, the left atrial incision was sutured continuously by prolene 4/0. Weaning from bypass start
Study NCT04360070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ketamine Hydrochloride
Description: Parenteral General Anesthetic
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Current Opioid Misuse Measure (COMM)-SWE
Description: Patients in test group should fulfill the the COMM and the battery of validation forms as well as leave the oral fluid for illicit drugs test and whole blod for phosphatidylethanol test.
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Oral fluid drug test
Description: Oral fluid sampling to detect drugs. Analysis with LC-HRMS
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PETh
Description: Alcohol use detection
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: ASI-SR
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: AUDIT
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DUDIT
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Brief Pain Inventory - BPI
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Patient Global Impression of Change PGIC
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: GAD-7
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Patient Health questionnaire (PHQ9)
Description: Cross-validation form
Study NCT06084520 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: DBS - cannabis test
Description: cross-validation form
Study NCT06084520 — intervention group
Intervention type: OTHER
Intervention: Sample of Blood for later DNA and immunological analysis in future studies
Description: sample collection for future studies
Study NCT05513989 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: modified Magill forceps
Description: modified pediatric Magill forceps was used to assist nasotracheal intubation.
Study NCT05513989 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Magill forceps
Description: Magill forceps was used to assist nasotracheal intubation.
Study NCT00012779 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Health Education Program
Study NCT05671432 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CM326
Description: CM326 injection
Study NCT05671432 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT04821466 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality Headset to provide a Virtual Reality Experience
Description: Participants will utilise a Virtual Reality experience for distraction therapy via a Virtual reality headset. Participants will wear the Virtual reality headset to be immersed in a multimedia experience.
Study NCT05277545 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Technology addiction education
Description: Technology addiction personal development training was applied by the researcher to the students in the experimental group for 10 weeks.
Study NCT05277545 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology addiction education
Description: Technology addiction personal development training was applied by the researcher to the students in the experimental group for 10 weeks.
Study NCT05171257 — intervention group
Intervention type: DRUG
Intervention: IV antibiotic treatment from prior
Description: patients receiving same IV antibiotic treatment from prior
Study NCT05171257 — intervention group
Intervention type: DRUG
Intervention: differing IV antibiotic treatment
Description: patients receiving differing IV antibiotics from prior
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength of lower trapezius
Description: Ask the patient to raise arm above the head with upper extremity in line with lower trapezius muscle fibers in prone position with the shoulder joint at 135 degrees. The patient will be asked to hold position 6 seconds and perform 3 sets of 10 repetitions and 3times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength of middle trapezius
Description: Shoulder external rotation with the shoulder abducted 90ₒ and elbow flexed 90ₒ in prone position with elbow supported on the table. The patient will be asked to hold position 6 seconds and perform 3 sets of 10 repetitions and 3times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Strength of serratus anterior
Description: Ask the patient to raise the arm on a wall in the plane of the scapula in standing position.~The patient will be asked to hold position 6 seconds and perform 3 sets of 10 repetitions and 3times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pulsed ultrasound
Description: With a 20% duty cycle, frequency of 1 MHz and intensity of 1.5 w/cm² for 5 minutes 3 times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pulsed ultrasound
Description: With a 20% duty cycle, frequency of 1 MHz and intensity of 1.5 w/cm² for 5 minutes 3 times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching of extensor carpi radialis brevis muscle
Description: Put the elbow in extension, forearm in pronation and wrist in flexion with ulnar deviation. Hold for 30s and repeat 3 times with 30s rest in between. Three times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Stretching of extensor carpi radialis brevis muscle
Description: Put the elbow in extension, forearm in pronation and wrist in flexion with ulnar deviation. Hold for 30s and repeat 3 times with 30s rest in between. Three times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Eccentric exercises of wrist extensors
Description: Ask the patient to extend elbow, pronate forearm, extend wrist and then flex the wrist slowly until full flexion is achieved. Patients should apply 3 sets of 10 repetitions 3 times per week for 6 weeks.
Study NCT05447468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Eccentric exercises of wrist extensors
Description: Ask the patient to extend elbow, pronate forearm, extend wrist and then flex the wrist slowly until full flexion is achieved. Patients should apply 3 sets of 10 repetitions 3 times per week for 6 weeks.
Study NCT05548621 — intervention group
Intervention type: OTHER
Intervention: Decision aid
Description: Online interactive decision aid for RCC
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Visual Evoked Potential (VEP)
Description: To assess the integrity of visual pathways through the optic nerves to the visual cortex, latencies and amplitudes of P100 will be measured after pattern-reversal stimuli.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visual Evoked Potential (VEP)
Description: To assess the integrity of visual pathways through the optic nerves to the visual cortex, latencies and amplitudes of P100 will be measured after pattern-reversal stimuli.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Somatosensory evoked potential (SSEP)
Description: To assess the integrity of sensitive pathways through the peripheral nerves and dorsal spinal cord to the somatosensory cortex. For the upper limbs, latencies and amplitudes of N9, N13, P14, N20 and P25 will be measured after median nerve stimulation. For the lower limbs, latency and amplitude of P40 will be measured after tibial nerve stimulation.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Somatosensory evoked potential (SSEP)
Description: To assess the integrity of sensitive pathways through the peripheral nerves and dorsal spinal cord to the somatosensory cortex. For the upper limbs, latencies and amplitudes of N9, N13, P14, N20 and P25 will be measured after median nerve stimulation. For the lower limbs, latency and amplitude of P40 will be measured after tibial nerve stimulation.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic motor evoked potentials (TCmMEP)
Description: To measure the integrity of motor pathways, the central conduction times will be measured for upper and lower limbs through magnetic stimulations of the primary motor cortex and the spinal cord, at cervical and lumbar levels.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic motor evoked potentials (TCmMEP)
Description: To measure the integrity of motor pathways, the central conduction times will be measured for upper and lower limbs through magnetic stimulations of the primary motor cortex and the spinal cord, at cervical and lumbar levels.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Tesla Brain MRI
Description: All patients will undergo a single brain MRI on a 3T scanner. The acquisition protocol will include high-resolution three-dimensional (3D) T2\*-weighted echo-planar imaging and 3D T2-FLAIR images acquired, respectively, during or after intravenous injection of a single dose (0.1mmol/kg) of gadolinium-based contrast material.
Study NCT05941975 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tesla Brain MRI
Description: All patients will undergo a single brain MRI on a 3T scanner. The acquisition protocol will include high-resolution three-dimensional (3D) T2\*-weighted echo-planar imaging and 3D T2-FLAIR images acquired, respectively, during or after intravenous injection of a single dose (0.1mmol/kg) of gadolinium-based contrast material.
Study NCT05941975 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood test - Neurofilament light chain (NfL)
Description: - Neurofilament light chain (NfL) will be tested (Quanterix's Simoa® Technology) in the serum of patients. To evaluate their variation over time, 3 time-point tests will be obtained at 6 months apart (at baseline, at 6- and 12-month follow-up).
Study NCT05941975 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood test - Neurofilament light chain (NfL)
Description: - Neurofilament light chain (NfL) will be tested (Quanterix's Simoa® Technology) in the serum of patients. To evaluate their variation over time, 3 time-point tests will be obtained at 6 months apart (at baseline, at 6- and 12-month follow-up).
Study NCT05941975 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Blood test - EBV serology
Description: EBV serology will be assessed (VCA IgG) in the serum of patients to evaluate the variation of antibody titers over time (at baseline, at 6- and 12-month follow-up), and compare to titers at the time of diagnosis (when available in their medical record).
Study NCT05941975 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood test - EBV serology
Description: EBV serology will be assessed (VCA IgG) in the serum of patients to evaluate the variation of antibody titers over time (at baseline, at 6- and 12-month follow-up), and compare to titers at the time of diagnosis (when available in their medical record).
Study NCT05041751 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture Point Injection
Description: Receive trigger point injections
Study NCT05041751 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Massage Therapy
Description: Perform myofascial release
Study NCT05041751 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05041751 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05041751 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT05041751 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06402708 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: paclitaxel 60mg/m2, ivgtt; cisplatin 30mg/m2, ivgtt; 5-FU 500mg/m2, ivgtt and 500mg/m2, civ 24h; calcium folinate 200mg; q3w.
Study NCT06402708 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Radiotherapy
Description: IMRT, 50Gy/25f
Study NCT05335460 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Envafolimab
Description: 300mg,sc,d1,Q3W
Study NCT05260619 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lenalidomide
Description: Patients with MRI documented response CR or PR after induction chemotherapy will enter the study protocol of lenalidomide maintenance (at a dose of 15 mg per day, on days 1 to 21 of each 28-day cycle) for up to 12 cycles or until the patients withdrew consent, the disease progressed, or unacceptable toxic effects occurred.